Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
36
Frequently Asked Questions
What is Market Cap of Viking Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Viking Therapeutics Inc market cap is $2.6B.
What is the 52-week high for Viking Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Viking Therapeutics Inc 52 week high is $81.73 as of September 18, 2025.
What is the 52-week low for Viking Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Viking Therapeutics Inc 52 week low is $18.92 as of September 18, 2025.
What is Viking Therapeutics Inc stock price today?
Viking Therapeutics Inc stock price today is $26.04.
What was Viking Therapeutics Inc stock price yesterday?
Viking Therapeutics Inc stock price yesterday was $23.09.
What is the PE ratio of Viking Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Viking Therapeutics Inc’s P/E ratio is -15.04.
What is the Price-to-Book ratio of Viking Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Viking Therapeutics Inc P/B ratio is 3.2606.
What is the 50-day moving average of Viking Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Viking Therapeutics Inc 50-day moving average is $30.74.
How many employess does Viking Therapeutics Inc has?